期刊文献+

异丙酚对心肌缺血/再灌注损伤的保护作用及机制研究进展 被引量:5

Research progression on the protective effects and mechanisms of propofol in myocardial ischemia/reperfusion injury
下载PDF
导出
摘要 异丙酚是一种在心脏手术中常用的脂溶性静脉麻醉药,具有与抗氧化剂维生素E类似的化学结构。体内外研究证实,异丙酚主要通过减轻氧化应激和炎症反应、保护线粒体功能及抑制细胞凋亡来对抗缺血/再灌注诱导的心肌损伤。此外,异丙酚还可以改善心肌缺血/再灌注后的血管内皮功能。然而,异丙酚应用于临床时对心肌缺血/再灌注损伤患者的心肌保护作用欠佳。异丙酚与气体麻醉药或抗氧化剂联合应用时对心肌缺血/再灌注损伤的防治效果可以加强。本文就异丙酚对心肌缺血/再灌注损伤的保护作用及机制进行综述。 Propofol is a fat-soluble intravenous anesthetic commonly used in heart surgery and has a chemical structure similar to the antioxidant vitamin E.In vitro and in vivo studies have demonstrated that propofol fights ischemia/reperfusion-induced myocardial injury primarily by mitigating oxidative stress and inflammatory responses,protecting mitochondrial function,and inhibiting apoptosis.In addition,propofol can improve endothelial function after myocardial ischemia/reperfusion.However,clinically,propofol has poor cardioprotection in patients with myocardial ischemia/reperfusion injury.Propofol can be combined with gas anesthetics or antioxidants to prevent and treat myocardial ischemia/reperfusion injury.This article summaries the roles and mechanisms of propofol in protecting myocardium against ischemia/reperfusion injury.
作者 韩荣辉(综述) 夏正远(审校) HAN Rong-hui;XIA Zheng-yuan(Department of Anesthesiology,the Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,CHINA)
出处 《海南医学》 CAS 2020年第21期2796-2799,共4页 Hainan Medical Journal
基金 国家自然科学基金(编号:81670770)。
关键词 心肌缺血/再灌注损伤 异丙酚 心肌保护 抗氧化 联合用药 Myocardial ischemia/reperfusion injury Propofol Cardioprotection Anti-oxidation Combined medication
  • 相关文献

参考文献9

二级参考文献63

  • 1李小鹰,王洁,何耀,范利.老年周围动脉硬化闭塞病与心血管疾病的关系——北京万寿路地区老年人群横断面调查[J].中华医学杂志,2003,83(21):1847-1851. 被引量:36
  • 2李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1785
  • 3谢俊然,郁丽娜,段世明.心肌缺血再灌注损伤心肌细胞凋亡的分子调节机制[J].国外医学(麻醉学与复苏分册),2005,26(4):226-228. 被引量:7
  • 4Wong E T, Tergaonkar V. Roles of NF-kappaB in health and disease : mechanisms and therapeutic potential [ J ]. Clin Sci (Lond), 2009, 116(6): 451-465. 被引量:1
  • 5Gutierrez S H, Kuri M R, delCastillo E R. Cardiac role of the transcription factor NF-kappaB [ J]. Cardiovasc Hematol Disord Drug Targets, 2008, 8(2) : 153-160. 被引量:1
  • 6Murphy P G, Myers D S, Davies W J, et al. The antioxidant potential of propofol ( 2, 6-diisopropylphenol) [ J ]. Br J Anaesth, 1992, 68(6): 613-618. 被引量:1
  • 7Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflanunatory diseases [ J]. Nat Rev Immunol, 2009, 9(11): 778-788. 被引量:1
  • 8Li C, Browder W, Kao R L. Early activation of transcription factor NF-κB during ischemia in perfused rat heart[J]. Am J Physiol, 1999, 276(2 pt 2) : H543-552. 被引量:1
  • 9Kin H, Wang N P, Mykytenko J, et al. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release [ J ]. Shock, 2008, 29 (6) : 761-768. 被引量:1
  • 10Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappa B binding site prevents myocardial infarction[J]. Nat Med, 1997, 3 (8) : 894-899. 被引量:1

共引文献1267

同被引文献80

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部